Genomic Valley Biotech Q2 FY27 Results: Net Loss of ₹0.02 Cr
Genomic Valley Biotech Ltd reported a net loss of ₹0.02 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.02 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Genomic Valley Biotech Ltd reported a net loss of ₹0.02 Cr for Q2 FY27.
Genomic Valley Biotech Ltd reported revenue from operations of ₹0.04 Cr (-57.8% YoY) and net profit of ₹0.01 Cr (-40.7% YoY) for Q1 FY27.
Genomic Valley Biotech Ltd reported revenue from operations of ₹0.04 Cr (-85.8% YoY) and a net loss of ₹0.01 Cr for Q4 FY26.
Genomic Valley Biotech approved FY26 audited results, reporting a total revenue of ₹0.27 Crore. The company also appointed Mr. Navjyoti Kumar Jha as Internal Auditor.